Risk factor
Very high price volatility
Profitability factor
Very low or no dividends
About
CareDx, Inc. discovers, develops, and commercializes diagnostic solutions for transplant patients and caregivers worldwide. It provides AlloSure Kidney, a donor-derived cell-free DNA (dd-cfDNA) solution for kidney transplant patients; AlloMap Heart, a gene expression solution for heart transplant patients; AlloSure Heart, a dd-cfDNA solution for heart transplant patients; and AlloSure Lung, a dd-cfDNA solution for lung...
Company Valuation
From both historical and forecast perspectives, the stock is fairly priced compared to similar stocks. Specifically, the stock is fairly valued on P/E, overpriced on P/FC
Target Price
The average target price of CDNA is 22 and suggests 14% upside potential. Usually, this means a HOLD recommendation among investment firms. This neutral recommendation su
Buy
Sell